N/A
N=80
MyPEEPS Mobile for Young Transgender Men
HIV
Bottom Line
View on ClinicalTrials.gov: NCT05424718 ↗Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Change in Condomless Receptive Sex Acts — 1.57; 3.19; 1.43; 1.44 Condomless Receptive Sex Acts
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- MyPEEPS Mobile (Behavioral)
- Age
- Pediatric, Adult · 15+ yrs
- Sex
- Female
- Sponsor
- Columbia University
- Primary completion
- Mar 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Condomless Receptive Sex Acts |
1.57; 3.19; 1.43; 1.44 | — |
| SECONDARY Self-reported Nonoccupational HIV Postexposure Prophylaxis (nPEP) Use |
1; 2; 1; 4 | — |
| SECONDARY Self-reported Pre-exposure Prophylaxis (PrEP) Use |
6; 7; 6; 7 | — |
| SECONDARY Self-reported HIV Testing |
12; 21; 15; 17 | — |
| SECONDARY Self-reported Sexually Transmitted Infections (STI) Testing |
19; 23; 19; 20 | — |
| SECONDARY Change in Partner PrEP Use and Adherence or Viral Suppression |
— | — |
Summary
The proposed MyPEEPS intervention for young transgender men is a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information to high risk youth. The final product will be the basis for conducting a large-scale efficacy study in this population.
Eligibility Criteria
Inclusion Criteria
To participate in any aspect of the study, participants must be:
- Between 15 and 25 years of age;
- Female sex assigned at birth;
- Identify as a transgender man or along the transmasculine spectrum (including a transmasculine non-binary gender; e.g., male, trans male, transmasculine gender non-binary);
- Understand and read English;
- Live within the US;
- Own a smartphone;
- Self-report condomless receptive anal or vaginal penile sex with either a cisgender male or transgender woman (e.g., individual designated or assigned male at birth) in the past year; and
- Self-report HIV-negative or unknown status.
Exclusion Criteria
Youth are ineligible to participate in the trial if:
- HIV positive;
- Unable to provide informed consent due to severe mental or physical illness or substance intoxication at the time of enrollment;
- Concurrently enrolled in another HIV prevention study.
Data sourced from ClinicalTrials.gov (NCT05424718). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.